Skip to main content
Premium Trial:

Request an Annual Quote

Sygnis Acquiring Expedeon for Cash, Stock

NEW YORK (GenomeWeb) – Biotech firm Sygnis said today that it is acquiring UK-based proteomics reagents company Expedeon.

The deal broadens Sygnis' genomics-focused product portfolio to include protein research and gives it access to Expedeon's sales forces in the US and Europe, the company said.

Sygnis will purchase Expedeon for €1.7 million ($1.9 million) in cash and an additional amount of stock, financing the transaction by issuing up to 20.5 million new shares, which will raise up to €20.5 million.

New shares not subscribed to in the offering will be offered to Expedeon shareholders as a contribution in kind against Expedeon shares. Sygnis said it intends to complete the acquisition by issuing roughly 80 percent of the new shares against Expedeon shares.

Sygnis said it expects to use €5 million from the capital raise to cover acquisition and integration costs and to provide working capital.

Sygnis has offices in Germany and Spain and specializes in the development and commercialization of DNA amplification and sequencing products. Expedeon's protein research products include RunBlue gels for electrophoresis, the VersaWave spectrophotometer for quantitation, and NVoy kits for refolding proteins.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.